Backed by a team of experienced professionals, our company is engaged in offering 400 mg-16Ml Bevacizumab Injection. This product is clinically tested and prescribed to treat a certain type of brain tumor as well as cancers of the colon, rectum, kidney, lung, or breast. We provide this 400 mg-16Ml Bevacizumab Injection in several packaging options according to the requirements. This injection acts by selectively binding circulating VEGF.
Product Type | Allopathic |
Strength | 400 Mg |
Shelf life | 2 Year |
Storage | 0-8 |
Dosage Form | 400mg |
Prescription/Non prescription | Prescription |
Treatment | CRC |
Composition | Bevacizumab |
Brand | Cizumab |
PREEGUS HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |